Clinical Oncology Next Generation Sequencing Ngs Market Size And Share

  • Report Code : TIPRE00007163
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025-2031年临床肿瘤学下一代测序（NGS）市场规模、份额及预测

Buy Now

Clinical Oncology Next Generation Sequencing (NGS) Market Report Clinical Oncology Next Generation Sequencing (NGS) Market Scope and Analysis Clinical Oncology Next Generation Sequencing (NGS) Market Size and Share

Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis

Clinical Oncology Next Generation Sequencing (NGS) Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Agilent Technologies, Inc.
  • Caris Life Sciences
  • F. Hoffmann-La Roche Ltd
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc
  • QIAGEN

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 技术
  • 全外显子组测序
  • 全基因组测序
  • 靶向测序和重测序
By 工作流程
  • NGS数据分析
  • NGS预测序
  • NGS测序
By 应用
  • 伴随诊断
  • 筛查
  • 其他应用
By 最终用户
  • 医院
  • 诊所
  • 实验室